Biohaven Ltd. cash flow to debt ratio of -214.13% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Biohaven Ltd.'s free cash flow has decreased 4.03% from $-586.50M last year to $-610.15M, signaling decreasing performance

Biohaven Ltd.'s debt to equity ratio is 2.21, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

Biohaven Ltd.'s debt has increased relative to shareholder equity from 0.09 last year to 2.21 today, signaling weakened financials

Biohaven Ltd. has negative EBITDA, making leverage ratio unreliable

Biohaven Ltd. earns at least as much interest as it pays. Interest obligations are fully covered.

Biohaven Ltd. has insufficient data to evaluate this check.

Biohaven Ltd.'s short-term assets of $368.33M exceed its short-term liabilities of $115.93M

Biohaven Ltd.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Biohaven Ltd.'s return on equity of -866.46%, is lower than 15.00%, indicating bad performance

Biohaven Ltd.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Biohaven Ltd. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Biohaven Ltd. has negative free cash flow, indicating the company is burning cash rather than generating it

Biohaven Ltd. has negative free cash flow, indicating cash burn

Biohaven Ltd.'s yearly earnings has increased -12.71% since last year from $-846.42M to $-738.82M, signaling increasing performance

Biohaven Ltd.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -155.69% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Biohaven Ltd. has insufficient revenue history to calculate 3-year revenue CAGR.

Biohaven Ltd. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

Biohaven Ltd. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Biohaven Ltd. has insufficient data to evaluate this check.

Biohaven Ltd. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Biohaven Ltd. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Biohaven Ltd. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Biohaven Ltd. has insufficient data to evaluate this check.

Biohaven Ltd. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Biohaven Ltd. has a price-to-book ratio of 17.03x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Biohaven Ltd. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue